Low-grade astrocytoma

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

6 events
Mar 2024Pilot Study of Vinblastine and Tovorafenib in Pediatric Patients With Recurrent/Progressive RAF Altered Low Grade Gliomas

Daniel Morgenstern — EARLY_PHASE1

TrialRECRUITING
Feb 2021A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma

National Cancer Institute (NCI) — PHASE3

TrialACTIVE NOT RECRUITING
Jan 2020A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

National Cancer Institute (NCI) — PHASE3

TrialRECRUITING
Aug 2018Trametinib for Pediatric Neuro-oncology Patients With Refractory Tumor and Activation of the MAPK/ERK Pathway.

St. Justine's Hospital — PHASE2

TrialACTIVE NOT RECRUITING
Oct 2016Glioma Microenvironment an Exploratory Study

Hospital Sirio-Libanes

TrialACTIVE NOT RECRUITING
Jul 2012Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma

Sun Yat-sen University — PHASE3

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Low-grade astrocytoma.
Check the disease page for updates →

Clinical Trial Landscape

3 active trials
3Phase 3
3Total recruiting
Search clinical trials for Low-grade astrocytoma

Recent News & Research

No recent news articles indexed yet for Low-grade astrocytoma.
Search PubMed for Low-grade astrocytoma

Browse all Low-grade astrocytoma news →

Specialist Network

Top 6 by expertise

View all Low-grade astrocytoma specialists →

Quick Actions